TRCT
TBI

Tower Research Capital (TRC)’s Trueblue TBI Stock Holding History

Tower Research Capital (TRC)’s Portfolio TBI Stock Details TBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5K Buy
2,938
+256
+10% +$1.14K ﹤0.01% 3837
2025
Q4 		$12.2K Buy
2,682
+65
+2% +$333 ﹤0.01% 3507
2025
Q3 		$16K Sell
2,617
-1,214
-32% -$7.68K ﹤0.01% 3501
2025
Q2 		$24.8K Sell
3,831
-1,635
-30% -$8.81K ﹤0.01% 3548
2025
Q1 		$29K Buy
5,466
+1,632
+43% +$11.1K ﹤0.01% 2643
2024
Q4 		$32.2K Sell
3,834
-8,047
-68% -$62.1K ﹤0.01% 2855
2024
Q3 		$93.7K Buy
11,881
+8,014
+207% +$72.1K ﹤0.01% 2283
2024
Q2 		$39.8K Buy
3,867
+1,302
+51% +$14.1K ﹤0.01% 3269
2024
Q1 		$32.1K Sell
2,565
-7,111
-73% -$92K ﹤0.01% 2595
2023
Q4 		$148K Buy
9,676
+9,014
+1,362% +$126K ﹤0.01% 2326
2023
Q3 		$9.71K Sell
662
-1,924
-74% -$30K ﹤0.01% 4188
2023
Q2 		$45.8K Buy
2,586
+1,938
+299% +$32.9K ﹤0.01% 2654
2023
Q1 		$12K Buy
648
+206
+47% +$3.85K ﹤0.01% 4125
2022
Q4 		$9K Sell
442
-2,963
-87% -$60.1K ﹤0.01% 4273
2022
Q3 		$65K Buy
3,405
+2,196
+182% +$44.4K ﹤0.01% 2928
2022
Q2 		$22K Buy
1,209
+881
+269% +$20.7K ﹤0.01% 3709
2022
Q1 		$9K Sell
328
-1,757
-84% -$48.3K ﹤0.01% 4494
2021
Q4 		$58K Sell
2,085
-4,426
-68% -$125K ﹤0.01% 2649
2021
Q3 		$176K Buy
6,511
+5,369
+470% +$144K ﹤0.01% 1933
2021
Q2 		$32K Sell
1,142
-13,825
-92% -$368K ﹤0.01% 3429
2021
Q1 		$330K Buy
14,967
+11,764
+367% +$241K 0.01% 1595
2020
Q4 		$60K Sell
3,203
-37,076
-92% -$667K ﹤0.01% 2919
2020
Q3 		$624K Buy
40,279
+32,393
+411% +$499K 0.01% 1443
2020
Q2 		$120K Buy
+7,886
New +$117K ﹤0.01% 2299
2020
Q1 		– Sell
-1,848
Closed -$44K – 3865
2019
Q4 		$44K Buy
1,848
+240
+15% +$5.47K ﹤0.01% 1425
2019
Q3 		$34K Buy
+1,608
New +$33.2K ﹤0.01% 2077
2019
Q2 		– Sell
-3,724
Closed -$88K – 4269
2019
Q1 		$88K Buy
3,724
+3,646
+4,674% +$85.1K 0.01% 1487
2018
Q4 		$2K Sell
78
-4,478
-98% -$107K ﹤0.01% 3443
2018
Q3 		$119K Sell
4,556
-436
-9% -$12.1K 0.01% 1248
2018
Q2 		$134K Buy
+4,992
New +$132K 0.01% 1261
2017
Q4 		– Sell
-7,219
Closed -$162K – 4003
2017
Q3 		$162K Buy
7,219
+6,819
+1,705% +$154K 0.01% 925
2017
Q2 		$11K Buy
+400
New +$10.7K ﹤0.01% 1583
2017
Q1 		– Sell
-557
Closed -$14K – 3883
2016
Q4 		$14K Buy
+557
New +$11.7K ﹤0.01% 2432
2016
Q3 		– Sell
-3,654
Closed -$69K – 4419
2016
Q2 		$69K Buy
+3,654
New +$76.3K 0.01% 1350
2016
Q1 		– Sell
-100
Closed -$3K – 4910
2015
Q4 		$3K Buy
+100
New +$2.7K ﹤0.01% 3510
2015
Q3 		– Sell
-557
Closed -$17K – 4739
2015
Q2 		$17K Sell
557
-6,922
-93% -$195K ﹤0.01% 2252
2015
Q1 		$182K Buy
7,479
+7,379
+7,379% +$166K 0.02% 468
2014
Q4 		$2K Sell
100
-9,034
-99% -$214K ﹤0.01% 3381
2014
Q3 		$231K Buy
+9,134
New +$253K 0.03% 474
2014
Q2 		– Sell
-1,725
Closed -$50K – 4626
2014
Q1 		$50K Buy
+1,725
New +$46.3K 0.01% 1095
2013
Q4 		– Sell
-1,940
Closed -$47K – 4912
2013
Q3 		$47K Buy
1,940
+405
+26% +$10.1K 0.01% 1965
2013
Q2 		$32K Buy
+1,535
New +$33.1K ﹤0.01% 1288

Other funds holding TBI

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Tower Research Capital (TRC)'s TBI Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Trueblue (TBI) stake by 9.5% in Q1 2026, buying an estimated $1.14K and bringing the position to 2,938 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3837.

Tower Research Capital (TRC) first reported a position in TBI in Q2 2013 and has held it in 42 quarters since. The position peaked at $624K in Q3 2020. 105 funds tracked by Wall St. Rank hold TBI as of Q1 2026.

  • Tower Research Capital (TRC) held 2,938 shares of Trueblue worth $11.5K as of Q1 2026.
  • Tower Research Capital (TRC) bought 256 Trueblue shares in Q1 2026, an estimated $1.14K.
  • Trueblue made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3837 holding.
  • Tower Research Capital (TRC) first reported a position in Trueblue in Q2 2013 and has held it in 42 quarters since.
  • Tower Research Capital (TRC)'s Trueblue position peaked at $624K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Trueblue as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.